Mark Hyman Rapaport, MD, is the chairman of the Department of Psychiatry and CEO of the Huntsman Mental Health Institute (HMHI). He serves as the second William H. and Edna D. Stimson Presidential Endowed Chair, University of Utah School of Medicine.
From 2011-2020, Mark was chairman of the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine and Chief of Psychiatric Services at Emory Healthcare in Atlanta, Georgia. Prior to that appointment, he was the chairman of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center and a professor of Psychiatry at both Cedar-Sinai and the David Geffen School of Medicine at UCLA.
Mark has received peer-reviewed grant funding from the National Institute of Mental Health (NIMH), the National Center for Complementary and Alternative Medicine, The Stanley Medical Research Institute, the Veterans Affairs Research Board and the National Alliance for Research on Schizophrenia and Depression (NARSAD) Foundation. His research interests focus on human psychoneuroimmunology, psychopharmacology research, clinical trial methodology, quality of life, and complementary and alternative medicine. He has written more than 190 articles for such peer-reviewed publications as The American Journal of Psychiatry, Biological Psychiatry, Journal of Clinical Psychiatry and Neuropsychopharmacology. Mark is board certified in Psychiatry by the American Board of Psychiatry and Neurology.